Cargando…
P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
Autores principales: | Korin, L., Fuente, M., Cranco, S., Vitriu, A., Ochoa, P., Babuin, E., Gelo, O., Ayala, L., Tempra, P., Venegas, M., Novoa, A., Vijnovich, A., Tartas, N., Custidiano, M. D. R., Foncuberta, M. C., Sanchez Avalos, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429470/ http://dx.doi.org/10.1097/01.HS9.0000847964.45968.60 |
Ejemplares similares
-
P041: Low percentage of T lymphocytes in Hodgkin’s Lymphoma lymph nodes, measured by flow cytometry, is associated with inferior progression free survival regardless of negative interim pet scan status
por: Korin, Laura, et al.
Publicado: (2022) -
PB2265: OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH B AND PLASMA CELL MALIGNANCIES DURING THE THIRD WAVE IN ARGENTINA: A SINGLE CENTER EXPERIENCE
por: Gelo, O., et al.
Publicado: (2022) -
Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia
por: Ruiz, María Sol, et al.
Publicado: (2018) -
Correction to Lancet Respir Med 2021; 9: 1275–87
Publicado: (2022) -
Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina
por: Mahuad, Carolina, et al.
Publicado: (2022)